TYSON WILLIAMS: Open Payments
NPI 1205512688 · FARGO, ND. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,274 in 75 payments from 19 companies in 2025. Trend: 2023 $680 · 2024 $1,498 · 2025 $1,274
Food & beverage: $1,274
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $164 |
| AstraZeneca Pharmaceuticals LP | 5 | $160 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $159 |
| Amgen Inc. | 10 | $153 |
| Boston Scientific Corporation | 2 | $113 |
| Novartis Pharmaceuticals Corporation | 5 | $89 |
| Phathom Pharmaceuticals, Inc. | 7 | $81 |
| Esperion Therapeutics, Inc. | 4 | $63 |
| Novo Nordisk Inc | 3 | $53 |
| PFIZER INC. | 3 | $48 |
Products named: BREZTRI, CAPLYTA, WATCHMAN FLX, VRAYLAR, LEQVIO, VOQUEZNA, EVENITY, NEXLETOL.
Industry payments across ND — which companies pay providers there.
